Skip to main content
The International Journal of Occupational and Environmental Medicine logoLink to The International Journal of Occupational and Environmental Medicine
. 2015 Jan 1;6(1):50–57. doi: 10.15171/ijoem.2015.436

Serum Neuron-Specific Enolase, Biogenic Amino-Acids and Neurobehavioral Function in Lead-Exposed Workers from Lead-Acid Battery Manufacturing Process

K Ravibabu 1, T Barman 1, HR Rajmohan 1
PMCID: PMC6977058  PMID: 25588226

Abstract

Background:

The interaction between serum neuron-specific enolase (NSE), biogenic amino-acids and neurobehavioral function with blood lead levels in workers exposed to lead form lead-acid battery manufacturing process was not studied.

Objective:

To evaluate serum NSE and biogenic amino-acids (dopamine and serotonin) levels, and neurobehavioral performance among workers exposed to lead from lead-acid storage battery plant, and its relation with blood lead levels (BLLs).

Methods:

In a cross-sectional study, we performed biochemical and neurobehavioral function tests on 146 workers exposed to lead from lead-acid battery manufacturing process. BLLs were assessed by an atomic absorption spectrophotometer. Serum NSE, dopamine and serotonin were measured by ELISA. Neurobehavioral functions were assessed by CDC-recommended tests—simple reaction time (SRT), symbol digit substitution test (SDST), and serial digit learning test (SDLT).

Results:

There was a significant correlation (r 0.199, p<0.05) between SDST and BLL. SDLT and SRT had also a significant positive correlation (r 0.238, p<0.01). NSE had a negative correlation (r –0.194, p<0.05) with serotonin level. Multiple linear regression analysis revealed that both SRT and SDST had positive significant associations with BLL. SRT also had a positive significant association with age.

Conclusion:

Serum NSE cannot be used as a marker for BLL. The only domain of neurobehavioral function tests that is affected by increased BLL in workers of lead-acid battery manufacturing process is that of the "attention and perception" (SDST).

Keywords: Lead, Enolase, Neuron-Specific, Dopamine, Serotonin, Neurobehavioral manifestations, Biogenic amines, Amino acids, Healthy worker effect


TAKE-HOME MESSAGE

  • Human exposure to lead by inhalation and ingestion caused accumulation of lead in erythrocytes, soft tissue (brain, kidney, and bone marrow) and mineralized tissue (bone, and teeth).

  • The most common neurological complaint of lead-exposed workers was irritability.

  • Serum NSE level increased with decrease in serotonin level. It cannot be used as a marker for BLL.

Introduction

Manufacturing lead-acid storage batteries involve processes, such as preparation of lead oxide, grid casting, pasting, plate cutting, formation, charging, and assembly. The chemicals lead oxide (PbO2), spongy lead (Pb) and sulfuric acid (H2SO4) used in these processes, are hazardous in nature. Human exposure to lead by inhalation and ingestion1 has potential risk; lead accumulates in erythrocytes, soft tissue (brain, kidney, and bone marrow) and mineralized tissue (bone, and teeth). Chronic lead exposure leads to a variety of health problems.2-5 The molecular mechanism of lead-induced neurotoxicity involves blocking the receptor of N-methyl-D-aspartate, which is involved in the maturation of brain plasticity, disturbing the blood-brain barrier, and secondary messenger of calcium ions through activation of G-protein.6 These effects cause impaired communication between astrocytes and endothelial cells, encephalopathy, and edema.

Neuron-specific enolase (NSE) is a glycolytic enzyme, enolase (2-phospho-D-glycerate hydrolysis), exists as several dimeric isoenzymes. Three isoenzymes are found in human brain—αα, αγ, and γγ. The αγ and γγ-enolase isoenzymes are also known as NSE, as these isoenzymes were initially detected in neurons and neuro-endocrine cells. Serum NSE has been used as a specific marker for neuron regeneration and re-innervation.7 The levels of serum NSE were associated with exposure to solvents,8 chromium,9 1-bromopropane,10 2,5-hexanedione,11 and patients with stroke and cardiac arrest.12,13

Serotonin and dopamine are biogenic amines. Serotonin is produced in both the central nervous system (CNS) and peripheral nervous system (PNS). In the CNS, serotonin is found to be associated with pain modulation, mood disorders, sleep disturbances, control of mood and anger, and regulation of body temperature. Serotonin produced in the PNS is associated with gastrointestinal motility and pain modulation.

Dopamine is related to the pleasure system. It promotes feelings of enjoyment and reinforcement to motivate performance. Dopamine has also functions in the brain related to motor coordination, cognition, mood, attention, and learning.

Serotonin is an inhibitory neurotransmitter, helps to calm the brain with regulation of memory, aggression, and violent behaviors. Dopamine is an excitatory neurotransmitter, associated with aggressive behaviors, and stimulates the brain.14 Low levels of serotonin have associated with impulsive behaviors and deregulations of dopamine systems.15

Animal studies reported that lead exposure altered motor behavior and the synaptosomal aminergic system,16 decreased serotonin in brain,17-19 increased dopamine in the basal ganglia,20 and decreased activity of neurotransmitters that ultimately affected the locomotive and cognitive functions.21

Increased number of errors, high response time in the symbol digit test, impaired memory,22 and poor scores in profile of mood states, tension-anxiety, hostility, and depression23 have been reported in lead smelter workers. Mild neurobehavioral dysfunctions were also noticed in those exposed to lead from printing house.24 The lead exposure affected the simple reaction time, digital symbol, correct dots and total dots.25 There are reports in lead battery workers on autonomic nervous system disorders,26 mood and motor coordination disturbances,27 alterations of dopamine and its metabolite, homovanillic acid, in urine associated with impaired neurobehavioral function,5 and poor scores for digit symbol, Bourdon-Wiersma, trail making test (part A), Santa Ana test, flicker fusion and simple reaction time,28 slow performance in psychomotor tasks, impaired processing of visual-spatial information, reduced memory and learning functions, low performance in doing accurate tasks, slow execution of responses, and poor attention control.29

So far, the interactions between serum NSE, biogenic amines and neurobehavioral function tests in workers exposed to lead from lead acid-storage battery manufacturing processes have not been studied. We therefore, conducted this study to evaluate the serum NSE and biogenic amino-acids (dopamine and serotonin) levels, and neurobehavioral function among workers exposed to lead from lead acid-storage battery manufacturing process.

Materials and Methods

In a cross-sectional study, we examined 146 workers exposed to lead from lead-acid battery manufacturing plant from Tamil Nadu, India. The serum NSE and biogenic amino-acids levels, and neurobehavioral function tests among lead-exposed workers were determined and compared in two categories of workers stratified by their blood lead levels (BLLs) using the cutoff value of 25 µg/dL set by CDC-NIOSH (ABLES),30 Adult Blood Lead Epidemiology and Surveillance.

Before including the workers in the study, an informed written consent was obtained from each of them. Personal habits of studied workers such as alcohol consumption, smoking, dietary pattern, occupational history, and subjective neurological complaints were recorded in a pre-designed questionnaire.

Three mL of venous blood was collected in heparinized vacuette from studied workers and stored at –20 °C until analysis. Two mL of the blood sample was digested by a microwave digestion system (ETHOS-D, Italy) with 2 mL of nitric acid (HNO3) and 0.2 mL of hydrogen peroxide (H2O2). The digested samples were made up to 5 mL using triple distilled water and centrifuged. The BLL was measured by an atomic absorption spectrophotometer (GBC-Avanta, Australia). Twenty µg/dL of the standard solution was prepared from the lead standard solution (Merck 1.19776.0500) and added to the lowest concentration of the sample. The analysis found 100% recovery with %RSD at <0.5 for three replicates.

Two mL of whole blood was collected in plain tubes and centrifuged at 3000 rpm for 10 min at 4 °C. The serum was separated and used for determination of NSE, dopamine, and serotonin.

The concentration of serum NSE was measured by ELISA (Cusabio Biotech Company Limited). The absorbance of standards and samples were measured by a molecular device microplate reader (USA) at 450 nm. The concentration of samples was determined by four parameter logistic (4-PL) regression model. The detection range was 1.56–100 ng/mL; the sensitivity was 0.39 ng/mL.

The serum dopamine and serotonin levels in lead-exposed workers were measured by ELISA (Causation Biotech Company Ltd). The absorbance of standards and samples were measured by a Molecular Device microplate reader at 450 nm. Concentrations of samples were determined by four parameter logistic (4-PL) regression model. The detection range of dopamine was 0.5–100 ng/mL and the sensitivity was 0.25 ng/mL. The parameters for serotonin were 4–800 ng/mL, and 2 ng/mL, respectively.

Neuropsychological functions were assessed in lead-exposed workers using CDC recommended tests31 including simple reaction time (SRT), symbol digit substitution (SDST) and serial digit learning (SDLT) tests.

Simple Reaction Time Test (SRT)

This test measures the visual motor speed and involves pressing a button when the color of an area on a screen turns from red into green. Web-based development SRT test was used (University of Washington faculty Web server). Five trials were administrated for each worker. The mean reaction time was chosen and expressed in ms. Shorter reaction time indicates better neurobehavioral performance.

Symbol Digit Substitution Test (SDST)

The test measures attention and perception. In this test, one to nine digits are paired with nine symbols in a grid. The subject matches the correct digits with jumbled symbols on a second grid. The total time taken for each person was measured and reported as the test result.

Serial Digit Learning Test (SDLT)

This test is a measure of learning recall and short memory. A string of eight numbers is presented. The subject must read, remember and enter the eight digits. A total score was calculated. If a subject’s response had fewer than six of the eight digits in correct positions, two points were added to the score. One point was added when either six or seven digits were in correct positions, no extra-point was added when all eight digits were correct.

Statistical Analysis

SPSS® for Windows® ver 17.0 was used for statistical analysis of the data. Student’s t test was used to compare mean of the measured variables between two groups. Pearson’s correlation coefficient was used to assess the relationship between BLL and serum NSE and biogenic amino-acids levels and neurobehavioral function tests results. Multiple linear regression analysis was used to evaluate the association between neurobehavioral function tests results and other studied variables. In the model, SRT, SDST, and SDLT were used as dependent variables and age, alcohol consumption, BLLs, BMI, service length, smoking, and NSE, dopamine and serotonin levels were used as independent variables. A p value <0.05 was considered statistically significant.

Results

The demographic details of workers exposed to lead are presented in Table 1. The most common neurological complaint of lead-exposed workers was irritability (Fig 1). SDST was the only neurobehavioral function test that was significantly longer in workers with BLL >25 µg/dL compared to those with lower BLLs (Table 2). SRT, SDLT, NSE, dopamine and serotonin levels were not significantly different between the two groups.

Table 1: Demographic details of lead-exposed workers. Numbers are either mean (SD) or frequency (%).
Parameters Workers (n=146)
Age (yrs) 36.0 (4.8)
Service length (yrs) 13.2 (3.6)
BMI (kg/m2) 25.8 (2.4)
Current smokers 33 (22.6%)
Alcohol users 78 (53.4%)
BP (mm Hg)
Systolic <140 118 (80.8%)
Systolic ≥140 28 (19.2%)
Diastolic <90 127 (87.0%)
Diastolic ≥90 19 (13.0%)

Figure 1.

Figure 1

The prevalence of neurological complaints reported by lead-exposed workers (n=146). Error bars represent 95% CI.

Table 2: Neurobehavioral function tests and neurochemical parameters in two subgroups of workers stratified by blood lead levels. Values are mean (SD).
Parameters Blood lead levels p value
≤25 (µg/dL)
(n=33)
>25 (µg/dL)
(n=113)
BLL (µg/dL) 19.6 (3.4) 36.9 (6.4) 0.001
SRT (ms) 312 (43.7) 330 (54.2) 0.056
SDST (s) 36.0 (13.8) 43 (19.1) 0.025
SDLT (error score) 0.3 (0.5) 0.3 (0.5) 0.671
NSE (ng/mL) 2.5 (1.3) 3.0 (1.9) 0.187
Dopamine (ng/mL) 11.0 (6.3) 13.0 (7.4) 0.403
Serotonin (ng/mL) 107.0 (48.3) 102.0 (48.9) 0.639

There was a significant correlation (r 0.199, p<0.05) between SDST and BLL. SDST was also correlated (r 0.191, p<0.05) with dopamine level. SDLT and SRT had also a significant positive correlation (r 0.238, p<0.01). Dopamine and serotonin levels were also positively correlated (r 0.225, p<0.05). NSE had a negative correlation (r –0.194, p<0.05) with serotonin level.

The results of multiple linear regression analysis of variables that would affect neurobehavioral functions among lead-exposed workers are shown in Table 3. Both SRT and SDST had positive significant associations with BLL. SRT also had a positive significant association with age.

Table 3.

Table 3: Multiple linear regression analysis results. Values are β (p value).
Independent Variables Dependent Variable
SRT (ms) SDST (s) SDLT (error score)
Age (yrs) 0.217 (0.029)* 0.086 (0.388) 0.059 (0.567)
Alcohol consumption 0.105 (0.227) –0.014 (0.869) 0.003 (0.977)
BLL (µg/dL) 0.235 (0.007)** 0.199 (0.022)* 0.063 (0.480)
BMI (kg/m2) 0.013 (0.879) –0.090 (0.307) 0.022 (0.812)
Service length (yrs) 0.072 (0.460) –0.002 (0.984) 0.006 (0.955)
Smoking –0.095 (0.283) 0.158 (0.074) –0.084 (0.361)
NSE (ng/mL) –0.080 (0.340) 0.007 (0.938) –0.151 (0.086)
Dopamine (ng/mL) –0.149 (0.086) –0.150 (0.086) 0.071 (0.432)
Serotonin (ng/mL) –0.021 (0.808) –0.083 (0.342) –0.111 (0.221)
r 2 0.128 0.119 0.045
*p<0.05; **p<0.01

Discussion

The present study assessed the neurobehavioral function tests and serum levels of NSE, dopamine and serotonin in lead-exposed workers from a lead-acid storage battery plant. Hanninen, et al ,32 reported that BLLs give a more accurate prediction for the neuropsychological effects of lead.

We found that SDST was significantly associated with BLL. This finding was similar to that reported by other studies24,33 that reported positive associations between BLL and neurobehavioral function tests in lead-exposed persons. Carta, et al ,22 also showed that a BLL >30 µg/dL is associated with increased number of errors and response time in SDT among lead smelter workers. Chen, et al ,29 showed significant impairment in neurobehavioral functions in workers with BLLs between 40 and 80 µg/dL that included slow performance of psychomotor tasks, impaired processing of visual-spatial information, reduced memory and learning functions, and resulted in slow execution of responses, and poor attention control. Balbus, et al34 reported a positive association between SRT and organolead exposure.

In the current study, we found that SRT was significantly associated with BLL and age of studied workers. Chanda Bash, et al ,16 also reported that lead exposure induced age-dependent alterations in motor behavior and synaptosomal aminergic system.

Originated from the brain, NSE is a protein commonly used to assess the presence and severity of neurological injury.35 Higher levels of serum NSE reported in patients with silicosis,36 mercury intoxication,37 pneumoconiosis,38 and those exposed to chromium9 and carbon-monoxide39. Lower levels of serum NSE were reported in workers exposed to organic solvents,8 and patients with major depressive and bipolar affective disorders.40 We found that in lead-exposed workers, serum NSE level was negatively correlated with serotonin level.

Deficiencies of monoamine degradation lead to cognitive, behavioral and autonomic disorders.41 Mansouri, et al ,17 reported that extracellular dopamine concentration was unaffected and serotonin concentration decreased in rats exposed to lead. Lead exposure caused a significant decrease in dopamine,18 the levels of norepinephrine, dopamine, and serotonin in different brain regions were also altered after lead exposure.19

Serotonin and dopamine play opposite roles in the CNS. It has been postulated that the decrease in serotonin observed among lead-exposed persons might be due to the inhibition of the activity-associated Ca+2-dependent release of neurotransmitters14 and the disruption of serotonin storage pools, leading to the increased degradation of serotonin inside the neurons by monoamines.42 Tang, et al , showed positive association between urinary homovanillic acid and BLLs, that dopamine was negatively correlated with Benton visual retention, and that homovanillic acid was negatively correlated with digit symbol, BVR, and pursuit aiming (PA) in lead-exposed workers.5 In the present study, multiple regression analysis showed that BLLs were positively associated with SRT and SDST.

In conclusion, serum NSE level increased with decrease in serotonin level. It cannot be used as a marker for BLL. The only domain of neurobehavioral function tests that is affected by increased BLL is that of the “attention and perception” (SDST). Therefore, SDST is the only neurobehavioral function test for the assessment of BLL in those working in lead-acid battery manufacturing process.

Conflicts of Interest:

None declared.

Cite this article as: Ravibabu K, Barman T, Rajmohan HR. Serum neuron-specific enolase, biogenic amino-acids and neurobehavioral function in lead-exposed workers from lead-acid battery manufacturing process. Int J Occup Environ Med 2015;6:50-57.

References

  • 1.Ibiebele DD. Air and blood lead levels in a battery factory. Sci Total Environ. 1994;152:269–73. doi: 10.1016/0048-9697(94)90317-4. [DOI] [PubMed] [Google Scholar]
  • 2.Suyama Y, Takaku S, Okawa Y, MatsukuboT MatsukuboT. Dental erosion in workers exposed to sulfuric acid in lead storage battery manufacturing facility. Bull Tokyo Dent Coll. 2010;51:77–83. doi: 10.2209/tdcpublication.51.77. [DOI] [PubMed] [Google Scholar]
  • 3.Kim KR, Lee SW, Paik NW, Choi K. Low-level lead exposure among South Korean lead workers, and estimates of associated risk of cardiovascular diseases. J Occup Environ Hyg. 2008;5:399–416. doi: 10.1080/15459620802081587. [DOI] [PubMed] [Google Scholar]
  • 4.Raafat BM, Hassan NS, Aziz SW. Bone mineral density (BMD) and osteoporosis risk factor in Egyptian male and female battery manufacturing workers. Toxicol Ind Health. 2012;28:245–52. doi: 10.1177/0748233711410912. [DOI] [PubMed] [Google Scholar]
  • 5.Tang HW, Liang YX, Hu XH, Yang HG. Alterations of monoamine metabolites and neurobehavioral function in lead-exposed workers. Biomed Environ Sci. 1995;8:23–9. [PubMed] [Google Scholar]
  • 6. Brochin R, Leone S, Phillips D, et al . The Cellular Effect of Lead Poisoning and Its Clinical Picture. GU Journal of Healh Science 2008;5:2. Available from https://blogs.commons.georgetown.edu/journal-of-health-sciences/files/Brochin-et-al-2008-GUJHS-5-2-The-Cellular-Effect-of-Lead-Poisoning-and-Its-Clinical-Picture.pdf (Accessed February 21, 2014).
  • 7.Takaaki K, Milton WB, Wolfgang HO. et al. Neuron-specific enolase as an index of neuronal regeneration and reinnervation. J Neurosci. 1983;3:915–23. doi: 10.1523/JNEUROSCI.03-05-00915.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Zungun C, Yilmaz FM, Tutkun E. et al. Assessment of serum S100B and neuron specific enolase levels to evaluate the neurotoxıc effects of organic solvent exposure. Clin Toxicol (Phila) 2013;51:748–51. doi: 10.3109/15563650.2013.820831. [DOI] [PubMed] [Google Scholar]
  • 9.Zagrodzki P, Debecki L, Radkowski A. et al. Association of occupational exposure to chromium with Tumour Markers and selected biochemical Parameters. Polish J Environ Stud. 2007;16:275–81. [Google Scholar]
  • 10.Gaku I, Joseph Keith M, Aldona Z. et al. Neurological disorders in three workers exposed to 1-Bromopropane. J Occup Health. 2002;44:1–7. [Google Scholar]
  • 11.Karlsson JE, Wang S, Rosengren LE, Haglid KG. Quantitative, alterations of S-100 Protein and Neuron specific enolase in the rat nervous system after chronic 2, 5-Hexanedione exposure. Neurochemical Research. 1993;18:203–8. doi: 10.1007/BF01474685. [DOI] [PubMed] [Google Scholar]
  • 12.Marjaana T, Risto OR, Ville P, Olli T. Serum neuron-specific enolase and S-100b protein in cardiac arrest patients treated with hypothermia. Stroke. 2003;34:2881–6. doi: 10.1161/01.STR.0000103320.90706.35. [DOI] [PubMed] [Google Scholar]
  • 13.Rech TH, Vieira SR, Nagel F. et al. Serum neuron-specific enolase as early predictor of outcome after in-hospital cardiac arrest: a cohort study. Critical Care. 2006;10:1–6. doi: 10.1186/cc5046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Haider Naqvi S, He R, Haleem DJ, Naqvi SW. Effect of serotonin and dopamine in Pb induced behavioral deficits in rats Pak. J Biochem Mol Biol. 2010;43:19–22. [Google Scholar]
  • 15.Seo D, Patrick CJ, Kennealy PJ. Role of Serotonin and Dopamine System Interactions in the Neurobiology of Impulsive Aggression and its Co- morbidity with other Clinical Disorders. Aggress Violent Behav. 2008;13:383–95. doi: 10.1016/j.avb.2008.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Chand Basha D, Saya Reddy N, Usha Rani M, Rajarami Reddy G. Age related changes in aminergic system and behavior following lead exposure: protection with essential metal supplements. Neurosci Res. 2014;78:81–9. doi: 10.1016/j.neures.2013.09.007. [DOI] [PubMed] [Google Scholar]
  • 17.Mansouri MT, Naghizadeh B, Lopez-Larrubia P, Cauli O. Behavioral deficits induced by lead exposure are accompanied by serotonergic and cholinergic alterations in the prefrontal cortex. Neurochem Int. 2013;62:232–9. doi: 10.1016/j.neuint.2012.12.009. [DOI] [PubMed] [Google Scholar]
  • 18.Fortune T, Lurie DI. Chronic low-level lead exposure affects the monoaminergic system in the mouse superior olivary complex. J Comp Neurol. 2009;513:542–58. doi: 10.1002/cne.21978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Flora SJ, Saxena G, Gautam P. et al. Response of lead-induced oxidative stress and alterations in biogenic amines in different rat brain regions to combined administration of DMSA and MiADMSA. Chem Biol Interact. 2007;170:209–20. doi: 10.1016/j.cbi.2007.08.003. [DOI] [PubMed] [Google Scholar]
  • 20.Szczerbak G, Nowak P, Kostrzewa RM, Brus R. Maternal lead exposure produces long-term enhancement of dopaminergic reactivity in rat offspring. Neurochem Res. 2007;32:1791–8. doi: 10.1007/s11064-007-9306-0. [DOI] [PubMed] [Google Scholar]
  • 21.Leret ML, Garcia-Uceda F, Antonio MT. Effects of maternal lead administration on monoaminergic, GABAergic and glutamatergic systems. Brain Res Bull. 2002;58:469–73. doi: 10.1016/s0361-9230(02)00819-5. [DOI] [PubMed] [Google Scholar]
  • 22.Carta P, Carta R, Aru G. et al. Neurobehavioral testing in lead smelter workers. G Ital Med Lav Ergon. 2005;27:285–9. [PubMed] [Google Scholar]
  • 23.Maizlish NA, Parra G, Feo O. Neurobehavioural evaluation of Venezuelan workers exposed to inorganic lead. Occup Environ Med. 1995;52:408–14. doi: 10.1136/oem.52.6.408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Niu Q, Dai F, Chen Y. Assessment for effect of low level lead-exposure on neurobehavior in workers of printing house. Wei Sheng Yan Jiu. 1998;27:365–6. [PubMed] [Google Scholar]
  • 25.Niu Q, He SC, Li HY. et al. A comprehensive neurobehavioral and neurophysiologic study for low level lead-exposed workers. G Ital Med Lav Ergon. 2000;22:299–304. [PubMed] [Google Scholar]
  • 26.Muzi G, Murgia N, Dell’Omo M. et al. Effects of inorganic lead exposure on the autonomic nervous system and on the variability of heart rate among workers at a battery plant. G Ital Med Lav Ergon. 2005;27S1:46–50. [PubMed] [Google Scholar]
  • 27.Cordeiro R, Lima Filho EC, Salgado PE. et al. Neurological disorders in workers with low levels of lead in the bloodII--Neuropsychological disorders. Rev Saude Publica. 1996;30:358–63. doi: 10.1590/s0034-89101996000400009. [DOI] [PubMed] [Google Scholar]
  • 28.Jeyaratnam J, Boey KW, Ong CN. et al. Neuropsychological studies on lead workers in Singapore. Br J Ind Med. 1986;43:626–9. doi: 10.1136/oem.43.9.626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Chen SS, Chen TJ, Lin CH. et al. Neurobehavioral changes in Taiwanese lead-exposed workers. J Occup Environ Med. 2005;47:902–8. doi: 10.1097/01.jom.0000169511.23124.6e. [DOI] [PubMed] [Google Scholar]
  • 30. Adult blood lead epidemiology & surveillance (ABLES). Available from www.cdc.gov/niosh/topics/ABLES/description.html (Accessed February 27, 2014).
  • 31. CDC-National health and nutrition examination survey III. Neurological testing procedure manual. Available from www.cdc.gov/nchs/data/nhanes/nhanes3/cdrom/manuals/neuro.pdf (Accessed February 27, 2014).
  • 32.Hanninen H, Aitio A, Kovala T. et al. Occupational exposure to lead and neuropsychological dysfunction. Occup Environ Med. 1998;55:202–9. doi: 10.1136/oem.55.3.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Krieg EF Jr, Chrislip DW, Crespo CJ. et al. The relationship between blood lead levels and neurobehavioral test performance in NHANES III and related occupational studies. Public Health Reports. 2005;120:250–51. doi: 10.1177/003335490512000305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Balbus JM, Stewart W, Bolla KI, Schwartz BS. Simple visual reaction time in organolead manufacturing workers: comparison of different methods of modeling lead exposure and reaction time. Am J Ind Med. 1997;32:544–9. doi: 10.1002/(sici)1097-0274(199711)32:5<544::aid-ajim17>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  • 35.Gempp E, Louge P, De Maistre S. et al. Neuron-specific enolase and S100B protein levels in recreational scuba divers with neurological decompression sickness. Diving Hyperb Med. 2014;44:26–9. [PubMed] [Google Scholar]
  • 36.Fang SC, Zhang HT, Wang CY, Zhang YM. Serum CA125 and NSE: Biomarkers of disease severity in patients with silicosis. Clin Chim Acta. 2014;10:123–7. doi: 10.1016/j.cca.2014.03.005. [DOI] [PubMed] [Google Scholar]
  • 37.Yılmaz FM, Yılmaz H, Tutkun E. et al. Serum biochemical markers of central nerve system damage in children with acute elemental mercury intoxicatıon. Clin Toxicol (Phila) 2014;52:32–8. doi: 10.3109/15563650.2013.860986. [DOI] [PubMed] [Google Scholar]
  • 38.Jiang FJ, Gao SJ, Meng J. et al. [Changes of serum neuron-specific enolase and serum ferritin levels in patients with pneumoconiosis] Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2013;31:534–5. [in Chinese]. [PubMed] [Google Scholar]
  • 39.Akelma AZ, Celik A, Ozdemir O. et al. Neuron-specific enolase and S100B protein in children with carbon monoxide poisoning: children are not just small adults. Am J Emerg Med. 2013;31:524–8. doi: 10.1016/j.ajem.2012.10.009. [DOI] [PubMed] [Google Scholar]
  • 40.Wiener CD, Jansen K, Ghisleni G. et al. Reduced serum levels of neuron specific enolase (NSE) in drug-naïve subjects with major depression and bipolar disorder. Neurochem Res. 2013;38:1394–8. doi: 10.1007/s11064-013-1036-x. [DOI] [PubMed] [Google Scholar]
  • 41.Pearl PL. Monoamine neurotransmitter deficiencies. Handb Clin Neurol. 2013;113:1819–25. doi: 10.1016/B978-0-444-59565-2.00051-4. [DOI] [PubMed] [Google Scholar]
  • 42.Struzynska L, Rafalowska U. The effect of lead on dopamine, GABA and histidine spontaneous and KCl dependent release from rat brain synaptosomes. Acta Neurobiol Exp. 1994;54:201–7. [PubMed] [Google Scholar]

Articles from The International Journal of Occupational and Environmental Medicine are provided here courtesy of Shiraz: NIOC Health Organization

RESOURCES